Chart, page-4871

Tarvold, it came down 20% since I called it overvalued.

Just under AUD 80mln pa revenue at 65% GM and liberal AUD 15mln pa other expenses gives just under AUD 40mln EBITDA. This is unconfirmed and communication from the company is not clear enough. So until final report with a presentation flushes out some doubts about growth, a PE of 10 for the next month would be appropriate IMO. That is AUD400mln or around $2.20-2.40 per share mark.

I expect that there will be significant news around vaccine from big pharma in the coming months which will fuel hope and dampen enthusiasm for sanitisers, at least in the collective psyche. People are just getting tired of lockdowns and desperately hoping for solutions. Personally, I don't think they will be effective vaccine but the news coverage will effect the sentiment.

Return question: what is your valuation and how do you derive it?